Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
•
Brachytherapy
•
Cervical Cancer
•
General Internal Medicine
Do you take patients off anticoagulation for tandem and ovoid or tandem and ring procedures?
Answer from: Radiation Oncologist at Community Practice
We don't take them off anti coagulant for intracaviatry alone unless using a hybrid applicator
Sign in or Register to read more
2795
Related Questions
How would you manage a female in her 40s with stage III cervical cancer with hydronephrosis and Crohn's disease?
How would you manage a cervical cancer patient with bulky PA LNs with direct extension and/or invasion into the lumbar vertebral bodies?
Between KEYNOTE A-18 and INTERLACE, for which patients would you recommend using one protocol over another?
Are there patient populations in whom you would consider using both induction chemotherapy and maintenance pembrolizumab for a patient with locally advanced cervical cancer?
How do you treat a locally advanced cervix cancer in a patient who declines brachytherapy?
Would you offer post operative radiation for a patient who had findings of lymphovascular invasion on salvage resection of a recurrent obturator node after definitive chemoradiation for cervical cancer?
How would you manage a recurrent cervical cancer previously treated with vaginal cuff brachytherapy and has had a complete response to chemo-immunotherapy?
How do you counsel patients about prognosis with FIGO 2018 IIIC cervix cancer managed in the new era of chemoradiation plus immunotherapy?
With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?
In patients treated with the KEYNOTE A-18 regimen who later recur, would you rechallenge with immunotherapy again?